- Home
- MIND vs VTGN Comparison
MIND vs VTGN Comparison
Compare MIND & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIND
- VTGN
- Stock Information
- Founded
- MIND 1987
- VTGN 1998
- Country
- MIND United States
- VTGN United States
- Employees
- MIND N/A
- VTGN N/A
- Industry
- MIND Industrial Machinery/Components
- VTGN Biotechnology: Pharmaceutical Preparations
- Sector
- MIND Industrials
- VTGN Health Care
- Exchange
- MIND Nasdaq
- VTGN Nasdaq
- Market Cap
- MIND 74.4M
- VTGN 82.7M
- IPO Year
- MIND 1994
- VTGN N/A
- Fundamental
- Price
- MIND $10.01
- VTGN $2.93
- Analyst Decision
- MIND
- VTGN
- Analyst Count
- MIND 0
- VTGN 0
- Target Price
- MIND N/A
- VTGN N/A
- AVG Volume (30 Days)
- MIND 393.7K
- VTGN 192.7K
- Earning Date
- MIND 12-10-2024
- VTGN 02-13-2025
- Dividend Yield
- MIND N/A
- VTGN N/A
- EPS Growth
- MIND N/A
- VTGN N/A
- EPS
- MIND 6.61
- VTGN N/A
- Revenue
- MIND $45,197,000.00
- VTGN $698,000.00
- Revenue This Year
- MIND $22.98
- VTGN N/A
- Revenue Next Year
- MIND $10.18
- VTGN N/A
- P/E Ratio
- MIND $1.51
- VTGN N/A
- Revenue Growth
- MIND 41.23
- VTGN N/A
- 52 Week Low
- MIND $3.05
- VTGN $2.22
- 52 Week High
- MIND $11.10
- VTGN $5.74
- Technical
- Relative Strength Index (RSI)
- MIND 62.10
- VTGN 53.66
- Support Level
- MIND $9.40
- VTGN $2.72
- Resistance Level
- MIND $9.75
- VTGN $3.10
- Average True Range (ATR)
- MIND 0.89
- VTGN 0.19
- MACD
- MIND 0.04
- VTGN 0.00
- Stochastic Oscillator
- MIND 64.84
- VTGN 66.00
About MIND MIND Technology Inc. (DE)
MIND Technology Inc provides technology and solutions for exploration, survey, and defense applications in oceanographic, hydrographic, defense, seismic, and security industries. The Company operates in segments namely, Seamap Marine Products and Klein Marine Products helps manufacture and sell specialized, high-performance sonar and seismic equipment. The company generates more revenue from Seamap Marine Products. The company's geographical segments include the United States; Europe, Russia & CIS; Middle East & Africa; Asia-Pacific; and Canada & Latin America.
About VTGN VistaGen Therapeutics Inc.
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.